Tenaya Therapeutics (TNYA)
0.68
-0.02 (2.86%)
Upcoming Events
Latest Headlines
Form SCHEDULE 13G Tenaya Therapeutics, Filed by: INTEGRATED CORE STRATEGIES (US) LLC
August 24, 2026 5:48 PM - SEC Filing
Form 4 Tenaya Therapeutics, For: Aug 17 Filed by: Ali Faraz
August 17, 2026 8:50 PM - SEC Filing
Form 4 Tenaya Therapeutics, For: Aug 17 Filed by: Tingley Whittemore
August 17, 2026 8:49 PM - SEC Filing
Form 144 Tenaya Therapeutics, Filed by: Ali Faraz
August 17, 2026 8:46 PM - SEC Filing
Form 144 Tenaya Therapeutics, Filed by: Tingley Whittemore
August 17, 2026 8:45 PM - SEC Filing
Tenaya Therapeutics, Inc. (TNYA) Misses Q2 EPS by 14c
August 5, 2026 6:22 PM - StreetInsider
Form S-8 Tenaya Therapeutics,
August 5, 2026 4:28 PM - SEC Filing
Form 10-Q Tenaya Therapeutics, For: Jun 30
August 5, 2026 4:19 PM - SEC Filing
Form 8-K Tenaya Therapeutics, For: Aug 05
August 5, 2026 4:14 PM - SEC Filing
Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 5, 2026 4:05 PM - Globe NewsWire
Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference
August 4, 2026 4:05 PM - Globe NewsWire
Form 3 Tenaya Therapeutics, For: Jul 13 Filed by: Hyllengren Eric J
July 14, 2026 9:04 PM - SEC Filing
Form 4 Tenaya Therapeutics, For: Jul 13 Filed by: Hyllengren Eric J
July 14, 2026 9:01 PM - SEC Filing
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
July 14, 2026 9:00 PM - Globe NewsWire
Piper Sandler on Tenaya Therapeutics Inc (TNYA): 'TN-301 Can Become a Key Value Driver for TNYA'
July 6, 2026 9:33 AM - StreetInsider
Form 8-K Tenaya Therapeutics, For: Jun 29
July 2, 2026 5:01 PM - SEC Filing
Form 8-K Tenaya Therapeutics, For: Jun 29
June 29, 2026 9:00 AM - SEC Filing
Tenaya Therapeutics names Eric Hyllengren as new CFO
June 29, 2026 8:32 AM - StreetInsider
Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer
June 29, 2026 8:30 AM - Globe NewsWire
Full Article List
